$21.580
+0.680 (+3.15%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
MLYS Prediction & Forecast by Similar Chart Analysis
Alphio's MLYS stock price prediction model matches the current Mineralys Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $21.78 (+0.91%). The 1-week path is $21.79 (+0.96%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Mineralys Therapeutics Inc Stock?
Given the current price of $20.30 and an RSI of 27.989, which indicates the stock is oversold, it may seem like a potential buy. However, the company has reported significant losses, with a net income of -241 million USD in Q2 2026 and a year-to-date change of -43.15%. Additionally, insider selling activity, while strategic, raises concerns about confidence in the stock. Therefore, the risks outweigh the potential rewards at this time.
MLYS stock price ended at $21.58 on Tuesday, after rising +3.15%
Mineralys Therapeutics Inc (MLYS) last closed at $21.58, gaining +3.15%. These facts feed the 1-day and 1-week MLYS price prediction above.
Forecast Drivers
Mineralys Therapeutics Inc (MLYS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches MLYS, ranked by similarity.
Seasonality analysis for MLYS
Historically the probability of a positive October return for MLYS is 76.67%. November offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for MLYS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Oct 2026 | $9.73 | $12.70 | $15.05 | -41.15% |
| Nov 2026 | $13.39 | $16.61 | $19.53 | -23.01% |
| Dec 2026 | $17.09 | $17.18 | $20.56 | -20.38% |
In 2026, Mineralys Therapeutics Inc (MLYS) is projected to range from $9.73 to $20.56.
Mineralys Therapeutics Inc 2026 monthly forecast
In Oct 2026, Mineralys Therapeutics Inc is projected to average $12.70, with a low of $9.73 and high of $15.05.
In Nov 2026, Mineralys Therapeutics Inc is projected to average $16.61, with a low of $13.39 and high of $19.53.
In Dec 2026, Mineralys Therapeutics Inc is projected to average $17.18, with a low of $17.09 and high of $20.56.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.